Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof

Details for Australian Patent Application No. 2005247565 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Kirsch, Reinhard; Baringhaus, KarlHeinz; Tennagels, Norbert; Petry, Stefan

Agent Watermark

Pub. Number AU-A-2005247565

PCT Pub. Number WO2005/116003

Priority 10 2004 026 532.1 29.05.04 DE

Filing date 14 May 2005

Wipo publication date 8 December 2005

International Classifications

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2005/116003 Priority application(s): WO2005/116003

8 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247567-4-hydroxy-4-methyl-piperidine-1-carbox ylic acid (4-methoxy-7-morpholin-4-yl-benzothia zol-2-yl)-amide

2005247557-Machine-readable security element for security products